Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

1.

Chronic pharmacological manipulation of dopamine receptors in brain.

Jenner P, Marsden CD.

Neuropharmacology. 1987 Jul;26(7B):931-40. Review.

PMID:
2889159
[PubMed - indexed for MEDLINE]
2.

The effect of chronic neuroleptic administration on cerebral dopamine receptor function.

Rupniak MN, Jenner P, Marsden CD.

Life Sci. 1983 May 16;32(20):2289-311. Review.

PMID:
6133203
[PubMed - indexed for MEDLINE]
3.

Receptor changes during chronic dopaminergic stimulation.

Jenner P, Boyce S, Marsden CD.

J Neural Transm Suppl. 1988;27:161-75. Review.

PMID:
2900291
[PubMed - indexed for MEDLINE]
4.
5.

Can the supersensitivity of rodents to dopamine be regarded as a model of tardive dyskinesia?

Wolfarth S, Ossowska K.

Prog Neuropsychopharmacol Biol Psychiatry. 1989;13(6):799-840. Review.

PMID:
2682786
[PubMed - indexed for MEDLINE]
6.

Parkinson's disease as a model for changes in dopamine receptor dynamics with aging.

Rinne UK.

Gerontology. 1982;28 Suppl 1:35-52. Review.

PMID:
7044903
[PubMed - indexed for MEDLINE]
7.

Short review on dopamine agonists: insight into clinical and research studies relevant to Parkinson's disease.

Radad K, Gille G, Rausch WD.

Pharmacol Rep. 2005 Nov-Dec;57(6):701-12. Review.

PMID:
16382188
[PubMed - indexed for MEDLINE]
Free Article
8.

The pharmacology of Parkinson's disease: basic aspects and recent advances.

Da Prada M, Keller HH, Pieri L, Kettler R, Haefely WE.

Experientia. 1984 Nov 15;40(11):1165-72. Review.

PMID:
6437857
[PubMed - indexed for MEDLINE]
9.

Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity?

Jeste DV, Wyatt RJ.

J Clin Psychiatry. 1981 Dec;42(12):455-7. Review.

PMID:
6118358
[PubMed - indexed for MEDLINE]
10.

[Development of dyskinesias induced by treatment for Parkinson's disease: potential role of first exposure to L-DOPA (or phenomenon of priming)].

Damier P, Tremblay L, Féger J, Hirsch EC.

Rev Neurol (Paris). 2000 Mar;156(3):224-35. Review. French.

PMID:
10740093
[PubMed - indexed for MEDLINE]
11.

Atypical antipsychotics: mechanism of action.

Seeman P.

Can J Psychiatry. 2002 Feb;47(1):27-38. Review.

PMID:
11873706
[PubMed - indexed for MEDLINE]
12.

Dopamine, GABA, cholecystokinin and opioids in neuroleptic-induced tardive dyskinesia.

Ebadi M, Hama Y.

Neurosci Biobehav Rev. 1988 Fall-Winter;12(3-4):179-87. Review.

PMID:
2906420
[PubMed - indexed for MEDLINE]
13.

Adaptive changes in brain dopamine function as a result of neuroleptic treatment.

Jenner P, Marsden CD.

Adv Neurol. 1988;49:417-31. Review. No abstract available.

PMID:
2894127
[PubMed - indexed for MEDLINE]
14.

Levodopa and dopamine agonists in the treatment of Parkinson's disease: advantages and disadvantages.

Ogawa N.

Eur Neurol. 1994;34 Suppl 3:20-8. Review.

PMID:
7821332
[PubMed - indexed for MEDLINE]
15.

GABA receptor agonists: pharmacological spectrum and therapeutic actions.

Bartholini G.

Med Res Rev. 1985 Jan-Mar;5(1):55-75. Review.

PMID:
2984490
[PubMed - indexed for MEDLINE]
16.

Serotonergic modulation of dopamine neurotransmission: a mechanism for enhancing therapeutics in schizophrenia.

Haleem DJ.

J Coll Physicians Surg Pak. 2006 Aug;16(8):556-62. Review.

PMID:
16899192
[PubMed - indexed for MEDLINE]
17.

Pharmacology of dopamine agonists in the treatment of Parkinson's disease.

Jenner P.

Neurology. 2002 Feb 26;58(4 Suppl 1):S1-8. Review.

PMID:
11909980
[PubMed - indexed for MEDLINE]
18.

Iron modulates neuroleptic-induced effects related to the dopaminergic system.

Ben-Shachar D, Livne E, Spanier I, Zuk R, Youdim MB.

Isr J Med Sci. 1993 Sep;29(9):587-92. Review.

PMID:
7901181
[PubMed - indexed for MEDLINE]
19.

Multiple dopamine receptors in brain and the pharmacological action of substituted benzamide drugs.

Jenner P, Marsden CD.

Acta Psychiatr Scand Suppl. 1984;311:109-23. Review.

PMID:
6142587
[PubMed - indexed for MEDLINE]
20.

[Current theories on the role of dopamine in the mechanism of action of neuroleptic drugs].

Płaźnik A, Kostowski W.

Psychiatr Pol. 1984 Jan-Feb;18(1):39-47. Review. Polish. No abstract available.

PMID:
6146150
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk